CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Name: CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Published: 2014
License: Public Domain

Wake Forest University Health Sciences · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

adult lymphocyte depletion hodgkin lymphoma, adult lymphocyte predominant hodgkin lymphoma, adult mixed cellularity hodgkin lymphoma, adult nasal type extranodal nk/t-cell lymphoma, adult nodular sclerosis hodgkin lymphoma, anaplastic large cell lymphoma, angioimmunoblastic t-cell lymphoma, hepatosplenic t-cell lymphoma, noncutaneous extranodal lymphoma, peripheral t-cell lymphoma, recurrent adult acute lymphoblastic leukemia, recurrent adult hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 968029
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.